Covea Finance’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.74M Sell
97,900
-8,200
-8% -$697K 0.24% 92
2026
Q1
$9.14M Sell
106,100
-4,100
-4% -$368K 0.32% 82
2025
Q4
$9.62M Sell
110,200
-41,300
-27% -$3.13M 0.32% 80
2025
Q3
$8.68M Buy
151,500
+4,400
+3% +$253K 0.3% 81
2025
Q2
$8.68M Buy
147,100
+70,700
+93% +$4.57M 0.32% 77
2025
Q1
$5.59M Sell
76,400
-174,120
-70% -$14.4M 0.26% 78
2024
Q4
$20.7M Sell
250,520
-53,480
-18% -$4.22M 0.93% 35
2024
Q3
$21.7M Sell
304,000
-11,000
-3% -$777K 0.95% 33
2024
Q2
$21.6M Sell
315,000
-400
-0.1% -$23.9K 0.99% 34
2024
Q1
$16.9M Buy
+315,400
New +$17M 0.8% 42

Other funds holding GMED

Covea Finance's GMED Position: Q2 2026 in Review

Covea Finance reduced its Globus Medical (GMED) stake by 7.7% in Q2 2026, selling an estimated $697K and leaving 97,900 shares worth $7.74M. The position accounts for 0.24% of the portfolio, ranked #92.

Covea Finance first reported a position in GMED in Q1 2024 and has held it in 10 quarters since. The position peaked at $21.7M in Q3 2024. 62 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Covea Finance held 97,900 shares of Globus Medical worth $7.74M as of Q2 2026.
  • Covea Finance sold 8,200 Globus Medical shares in Q2 2026, an estimated $697K.
  • Globus Medical made up 0.24% of Covea Finance's portfolio in Q2 2026, its #92 holding.
  • Covea Finance first reported a position in Globus Medical in Q1 2024 and has held it in 10 quarters since.
  • Covea Finance's Globus Medical position peaked at $21.7M in Q3 2024.
  • 62 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Covea Finance's 13F filing for Q2 2026, filed 13 Jul 2026.